Featured essay
Sterile Biologics Capacity Crunch: How to Secure CDMO Slots in 2026Modern Catalyst The biologics revolution is colliding with manufacturing reality. As monoclonal antibodies, cell and gene therapies, and biosimilars flood development pipelines, contract development and manufacturing organizations (CDMOs) face an unprecedented capacity crisis. T…
Read full essay